Home › Companies › CORBUS PHARMACEUTICALS HOLDINGS INC. › 2024-2025

CORBUS PHARMACEUTICALS HOLDINGS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and CORBUS PHARMACEUTICALS HOLDINGS INC.’s Form 8-K, filed May 19, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.

9Ballot items
105Asset managers
906Fund votes
May 15, 2025Meeting date

Results at a glance

Meeting of May 15, 2025: 9 items on CORBUS PHARMACEUTICALS HOLDINGS INC.’s Form 8-K, filed May 19, 2025: 1 approved · 8 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2024-2025

Explore CORBUS PHARMACEUTICALS HOLDINGS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by CORBUS PHARMACEUTICALS HOLDINGS INC.

These tallies are CORBUS PHARMACEUTICALS HOLDINGS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 19, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

CORBUS PHARMACEUTICALS HOLDINGS INC. — official shareholder meeting results, meeting held May 15, 2025
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Yuval Cohen	6,681,546	--	--	65,244	2,281,655	99.0%	Not verified	—
Elect Director: Alan Holmer	6,678,977	--	--	67,813	2,281,655	99%	Not verified	—
Elect Director: Rachelle Jacques	6,634,539	--	--	112,251	2,281,655	98%	Not verified	—
Elect Director: John Jenkins	6,681,768	--	--	65,022	2,281,655	99.0%	Not verified	—
Elect Director: Anne Altmeyer	6,677,977	--	--	68,813	2,281,655	99%	Not verified	—
Elect Director: Yong Ben	6,667,049	--	--	79,741	2,281,655	99%	Not verified	—
Elect Director: Winston Kung	6,568,610	--	--	178,180	2,281,655	97%	Not verified	—
2. Proposal to ratify the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2025	8,841,947	154,305	32,193	--	--	98%	Approved	—
Proposal 3: The votes were cast as follows with respect to the proposal to vote, on an advisory basis, on the compensation of the Company's named executive officers as described in the Company's definitive proxy statement:	6,519,904	215,784	11,102	--	2,281,655	97%	Not verified	—

Source: CORBUS PHARMACEUTICALS HOLDINGS INC., Form 8-K, filed with the SEC on May 19, 2025 — read the filing on EDGAR.

How asset managers voted at the CORBUS PHARMACEUTICALS HOLDINGS INC. 2024-2025 meeting

Each item below shows how the 105 asset managers that disclosed a CORBUS PHARMACEUTICALS HOLDINGS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Alan Holmer

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 6,678,977WITHHELD: 67,813

Details: description as filed, official tally, votes by 31 asset managers

Description as filed by funds: Election of Directors: Alan Holmer

CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Elect Director: Alan Holmer”): 6,678,977 for, 67,813 withheld, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 31 asset managers below reported 1,063,512 for, 1,045 withheld.

FOR

FOR: 1,063,512WITHHOLD: 1,045

Largest asset managers voting on “Election of Directors: Alan Holmer” at CORBUS PHARMACEUTICALS HOLDINGS INC., 2024-2025
Asset manager	For	Withheld	Vote
Vanguard	645,417	0	For
BlackRock	155,344	0	For
Charles Schwab	95,142	0	For
Victory Capital	33,978	0	For
Fidelity	27,153	0	For
Aberdeen	26,894	0	For
Equitable	16,099	0	For
Goldman Sachs	14,342	0	For
Lincoln Financial	8,100	0	For
Northern Trust	7,898	0	For
Global X	6,696	0	For
Pacific Life	4,740	0	For
John Hancock	4,203	0	For
Bridge Builder Trust	3,404	0	For
ProShares	2,541	0	For
Nationwide	1,935	0	For
DWS	1,801	0	For
SEI	1,700	0	For
Brighthouse	1,370	0	For
AIG/SunAmerica	1,291	0	For
Calvert	0	996	Withhold
Columbia Threadneedle	926	0	For
Voya	844	0	For
State Street	492	0	For
Brinker Capital Destinations Trust	400	0	For

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

2. Elect Director: Anne Altmeyer

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 6,677,977WITHHELD: 68,813

Details: description as filed, official tally, votes by 31 asset managers

Description as filed by funds: Election of Directors: Anne Altmeyer

CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Elect Director: Anne Altmeyer”): 6,677,977 for, 68,813 withheld, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 31 asset managers below reported 1,064,557 for.

FOR

FOR: 1,064,557

Largest asset managers voting on “Election of Directors: Anne Altmeyer” at CORBUS PHARMACEUTICALS HOLDINGS INC., 2024-2025
Asset manager	For	Vote
Vanguard	645,417	For
BlackRock	155,344	For
Charles Schwab	95,142	For
Victory Capital	33,978	For
Fidelity	27,153	For
Aberdeen	26,894	For
Equitable	16,099	For
Goldman Sachs	14,342	For
Lincoln Financial	8,100	For
Northern Trust	7,898	For
Global X	6,696	For
Pacific Life	4,740	For
John Hancock	4,203	For
Bridge Builder Trust	3,404	For
ProShares	2,541	For
Nationwide	1,935	For
DWS	1,801	For
SEI	1,700	For
Brighthouse	1,370	For
AIG/SunAmerica	1,291	For
Calvert	996	For
Columbia Threadneedle	926	For
Voya	844	For
State Street	492	For
Brinker Capital Destinations Trust	400	For

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

3. Elect Director: John Jenkins

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%

FOR: 6,681,768WITHHELD: 65,022

Details: description as filed, official tally, votes by 31 asset managers

Description as filed by funds: Election of Directors: John Jenkins

CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Elect Director: John Jenkins”): 6,681,768 for, 65,022 withheld, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.0% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 31 asset managers below reported 1,064,557 for.

FOR

FOR: 1,064,557

Largest asset managers voting on “Election of Directors: John Jenkins” at CORBUS PHARMACEUTICALS HOLDINGS INC., 2024-2025
Asset manager	For	Vote
Vanguard	645,417	For
BlackRock	155,344	For
Charles Schwab	95,142	For
Victory Capital	33,978	For
Fidelity	27,153	For
Aberdeen	26,894	For
Equitable	16,099	For
Goldman Sachs	14,342	For
Lincoln Financial	8,100	For
Northern Trust	7,898	For
Global X	6,696	For
Pacific Life	4,740	For
John Hancock	4,203	For
Bridge Builder Trust	3,404	For
ProShares	2,541	For
Nationwide	1,935	For
DWS	1,801	For
SEI	1,700	For
Brighthouse	1,370	For
AIG/SunAmerica	1,291	For
Calvert	996	For
Columbia Threadneedle	926	For
Voya	844	For
State Street	492	For
Brinker Capital Destinations Trust	400	For

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

4. Elect Director: Rachelle Jacques

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 6,634,539WITHHELD: 112,251

Details: description as filed, official tally, votes by 31 asset managers

Description as filed by funds: Election of Directors: Rachelle Jacques

CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Elect Director: Rachelle Jacques”): 6,634,539 for, 112,251 withheld, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 31 asset managers below reported 1,063,561 for, 996 withheld.

FOR

FOR: 1,063,561WITHHOLD: 996

Largest asset managers voting on “Election of Directors: Rachelle Jacques” at CORBUS PHARMACEUTICALS HOLDINGS INC., 2024-2025
Asset manager	For	Withheld	Vote
Vanguard	645,417	0	For
BlackRock	155,344	0	For
Charles Schwab	95,142	0	For
Victory Capital	33,978	0	For
Fidelity	27,153	0	For
Aberdeen	26,894	0	For
Equitable	16,099	0	For
Goldman Sachs	14,342	0	For
Lincoln Financial	8,100	0	For
Northern Trust	7,898	0	For
Global X	6,696	0	For
Pacific Life	4,740	0	For
John Hancock	4,203	0	For
Bridge Builder Trust	3,404	0	For
ProShares	2,541	0	For
Nationwide	1,935	0	For
DWS	1,801	0	For
SEI	1,700	0	For
Brighthouse	1,370	0	For
AIG/SunAmerica	1,291	0	For
Calvert	0	996	Withhold
Columbia Threadneedle	926	0	For
Voya	844	0	For
State Street	492	0	For
Brinker Capital Destinations Trust	400	0	For

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

5. Elect Director: Winston Kung

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 6,568,610WITHHELD: 178,180

Details: description as filed, official tally, votes by 31 asset managers

Description as filed by funds: Election of Directors: Winston Kung

CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Elect Director: Winston Kung”): 6,568,610 for, 178,180 withheld, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 31 asset managers below reported 961,019 for, 103,538 withheld.

FOR

FOR: 961,019WITHHOLD: 103,538

Largest asset managers voting on “Election of Directors: Winston Kung” at CORBUS PHARMACEUTICALS HOLDINGS INC., 2024-2025
Asset manager	For	Withheld	Vote
Vanguard	645,417	0	For
BlackRock	155,344	0	For
Charles Schwab	0	95,142	Withhold
Victory Capital	33,978	0	For
Fidelity	27,153	0	For
Aberdeen	26,894	0	For
Equitable	16,099	0	For
Goldman Sachs	14,342	0	For
Lincoln Financial	8,100	0	For
Northern Trust	7,898	0	For
Global X	0	6,696	Withhold
Pacific Life	4,740	0	For
John Hancock	4,203	0	For
Bridge Builder Trust	3,404	0	For
ProShares	2,541	0	For
Nationwide	1,935	0	For
DWS	1,801	0	For
SEI	0	1,700	Withhold
Brighthouse	1,370	0	For
AIG/SunAmerica	1,291	0	For
Calvert	996	0	For
Columbia Threadneedle	926	0	For
Voya	844	0	For
State Street	492	0	For
Brinker Capital Destinations Trust	400	0	For

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

6. Elect Director: Yong Ben

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 6,667,049WITHHELD: 79,741

Details: description as filed, official tally, votes by 31 asset managers

Description as filed by funds: Election of Directors: Yong Ben

CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Elect Director: Yong Ben”): 6,667,049 for, 79,741 withheld, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 31 asset managers below reported 1,064,557 for.

FOR

FOR: 1,064,557

Largest asset managers voting on “Election of Directors: Yong Ben” at CORBUS PHARMACEUTICALS HOLDINGS INC., 2024-2025
Asset manager	For	Vote
Vanguard	645,417	For
BlackRock	155,344	For
Charles Schwab	95,142	For
Victory Capital	33,978	For
Fidelity	27,153	For
Aberdeen	26,894	For
Equitable	16,099	For
Goldman Sachs	14,342	For
Lincoln Financial	8,100	For
Northern Trust	7,898	For
Global X	6,696	For
Pacific Life	4,740	For
John Hancock	4,203	For
Bridge Builder Trust	3,404	For
ProShares	2,541	For
Nationwide	1,935	For
DWS	1,801	For
SEI	1,700	For
Brighthouse	1,370	For
AIG/SunAmerica	1,291	For
Calvert	996	For
Columbia Threadneedle	926	For
Voya	844	For
State Street	492	For
Brinker Capital Destinations Trust	400	For

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

7. Elect Director: Yuval Cohen

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%

FOR: 6,681,546WITHHELD: 65,244

Details: description as filed, official tally, votes by 31 asset managers

Description as filed by funds: Election of Directors: Yuval Cohen

CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Elect Director: Yuval Cohen”): 6,681,546 for, 65,244 withheld, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 31 asset managers below reported 1,064,557 for.

FOR

FOR: 1,064,557

Largest asset managers voting on “Election of Directors: Yuval Cohen” at CORBUS PHARMACEUTICALS HOLDINGS INC., 2024-2025
Asset manager	For	Vote
Vanguard	645,417	For
BlackRock	155,344	For
Charles Schwab	95,142	For
Victory Capital	33,978	For
Fidelity	27,153	For
Aberdeen	26,894	For
Equitable	16,099	For
Goldman Sachs	14,342	For
Lincoln Financial	8,100	For
Northern Trust	7,898	For
Global X	6,696	For
Pacific Life	4,740	For
John Hancock	4,203	For
Bridge Builder Trust	3,404	For
ProShares	2,541	For
Nationwide	1,935	For
DWS	1,801	For
SEI	1,700	For
Brighthouse	1,370	For
AIG/SunAmerica	1,291	For
Calvert	996	For
Columbia Threadneedle	926	For
Voya	844	For
State Street	492	For
Brinker Capital Destinations Trust	400	For

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

8. Proposal 3: The votes were cast as follows with respect to the proposal to vote, on an advisory basis, on the…

Outcome not verified Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 6,519,904AGAINST: 215,784

Details: description as filed, official tally, votes by 105 asset managers

Description as filed by funds: APPROVAL, ON AN ADVISORY BASIS, OF THE EXECUTIVE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.

CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“Proposal 3: The votes were cast as follows with respect to the proposal to vote, on an advisory basis, on the compensation of the Company's named executive officers as described in the Company's definitive proxy statemen”): 6,519,904 for, 215,784 against, per its Form 8-K filed May 19, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 31 asset managers voting on “APPROVAL, ON AN ADVISORY BASIS, OF THE EXECUTIVE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at CORBUS PHARMACEUTICALS HOLDINGS INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	645,417	0	For
BlackRock	155,344	0	For
Charles Schwab	95,142	0	For
Victory Capital	33,978	0	For
Fidelity	27,153	0	For
Aberdeen	0	26,894	Against
Equitable	6,179	9,920	Mixed
Goldman Sachs	0	14,342	Against
Lincoln Financial	8,100	0	For
Northern Trust	7,898	0	For
Global X	6,696	0	For
Pacific Life	4,740	0	For
John Hancock	4,203	0	For
Bridge Builder Trust	3,404	0	For
ProShares	2,541	0	For
Nationwide	1,935	0	For
DWS	1,801	0	For
SEI	1,700	0	For
Brighthouse	1,370	0	For
AIG/SunAmerica	1,291	0	For
Calvert	0	996	Against
Columbia Threadneedle	926	0	For
Voya	844	0	For
State Street	492	0	For
Brinker Capital Destinations Trust	400	0	For

Fund voting reports, all 31 managers: 1,012,405 for, 52,152 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 88 asset managers voting on “APPROVAL, ON AN ADVISORY BASIS, OF THE EXECUTIVE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at CORBUS PHARMACEUTICALS HOLDINGS INC., 2024-2025
Asset manager	For	Against	Vote
Octagon Capital Advisors LP	1,115,000	0	For
Cormorant Asset Management, LP	1,112,072	0	For
ORBIMED ADVISORS LLC	849,387	0	For
BlackRock	262,741	0	For
ARMISTICE CAPITAL, LLC	236,000	0	For
Exome Asset Management LLC	188,100	0	For
Global X	148,245	0	For
Prosight Management, LP	113,850	0	For
Charles Schwab	95,144	0	For
State Street	93,063	12	For
HighVista Strategies LLC	75,292	0	For
Vivo Capital, LLC	75,153	0	For
ADAGE CAPITAL PARTNERS GP, L.L.C.	50,000	0	For
Citadel	45,103	0	For
Northern Trust	42,514	0	For
Victory Capital	37,668	0	For
GEODE CAPITAL MANAGEMENT, LLC	35,748	0	For
Two Sigma	34,559	0	For
Stonepine Capital Management, LLC	30,000	0	For
Aberdeen	0	26,894	Against
AQR	25,990	0	For
Vanguard	19,777	0	For
Nuveen	17,871	0	For
MELLON INVESTMENTS Corp	0	15,370	Against
AllianceBernstein	0	10,033	Against

Institutional-manager reports, all 88 managers: 4,774,547 for, 74,760 against. Showing the 25 largest; see all in the interactive database.

9. 2. Proposal to ratify the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%

FOR: 8,841,947AGAINST: 154,305

Details: description as filed, official tally, votes by 31 asset managers

Description as filed by funds: Ratification of EisnerAmper LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.

CORBUS PHARMACEUTICALS HOLDINGS INC.’s own tally for this item (“2. Proposal to ratify the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2025”): 8,841,947 for, 154,305 against — passed, per its Form 8-K filed May 19, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to ratify the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2025, was approved based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 31 asset managers below reported 1,064,557 for.

FOR

FOR: 1,064,557

Largest asset managers voting on “Ratification of EisnerAmper LLP as the Company's independent registered public accounting firm for the year en” at CORBUS PHARMACEUTICALS HOLDINGS INC., 2024-2025
Asset manager	For	Vote
Vanguard	645,417	For
BlackRock	155,344	For
Charles Schwab	95,142	For
Victory Capital	33,978	For
Fidelity	27,153	For
Aberdeen	26,894	For
Equitable	16,099	For
Goldman Sachs	14,342	For
Lincoln Financial	8,100	For
Northern Trust	7,898	For
Global X	6,696	For
Pacific Life	4,740	For
John Hancock	4,203	For
Bridge Builder Trust	3,404	For
ProShares	2,541	For
Nationwide	1,935	For
DWS	1,801	For
SEI	1,700	For
Brighthouse	1,370	For
AIG/SunAmerica	1,291	For
Calvert	996	For
Columbia Threadneedle	926	For
Voya	844	For
State Street	492	For
Brinker Capital Destinations Trust	400	For

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

Largest CORBUS PHARMACEUTICALS HOLDINGS INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 12,236,767 shares outstanding at the time of that meeting.

Fund voting reports: top CORBUS PHARMACEUTICALS HOLDINGS INC. shareholders by shares voted on “APPROVAL, ON AN ADVISORY BASIS, OF THE EXECUTIVE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE…”, 2024-2025
#	Asset manager	% of shares outstanding
1	Vanguard	5.27%
2	BlackRock	1.27%
3	Charles Schwab	0.78%
4	Victory Capital	0.28%
5	Fidelity	0.22%
6	Aberdeen	0.22%
7	Equitable	0.13%
8	Goldman Sachs	0.12%
9	Lincoln Financial	0.07%
10	Northern Trust	0.06%

Institutional-manager reports: top CORBUS PHARMACEUTICALS HOLDINGS INC. shareholders by shares voted on “APPROVAL, ON AN ADVISORY BASIS, OF THE EXECUTIVE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE…”, 2024-2025
#	Asset manager	% of shares outstanding
1	Octagon Capital Advisors LP	9.11%
2	Cormorant Asset Management, LP	9.09%
3	ORBIMED ADVISORS LLC	6.94%
4	BlackRock	2.15%
5	ARMISTICE CAPITAL, LLC	1.93%
6	Exome Asset Management LLC	1.54%
7	Global X	1.21%
8	Prosight Management, LP	0.93%
9	Charles Schwab	0.78%
10	State Street	0.76%

Reported CORBUS PHARMACEUTICALS HOLDINGS INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

CORBUS PHARMACEUTICALS HOLDINGS INC. holdings and ownership disclosed for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
Cormorant Global Healthcare Master Fund, LP	19.41%	DEF14A
Aberdeen Group plc	10.80%	13G
OrbiMed Capital LLC	9.58%	DEF14A
Octagon Capital Advisors LP	9.11%	DEF14A
Kenneth Griffin	8.01%	13G
BlackRock	6.91%	13F
Vanguard Group	5.49%	13F
Renaissance Technologies	2.82%	13F
Yuval Cohen	1.91%	DEF14A
State Street	1.83%	13F

Percentages above are of 12,236,767 shares outstanding, as reported by CORBUS PHARMACEUTICALS HOLDINGS INC. on its Form 10-Q dated May 2, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CORBUS PHARMACEUTICALS HOLDINGS INC.’s 10-Q dated May 2, 2025. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At CORBUS PHARMACEUTICALS HOLDINGS INC.'s shareholder meeting held May 15, 2025, in the 2024-2025 proxy season, 105 asset managers reported how they voted on 9 ballot items in their SEC Form N-PX filings, covering 906 separate fund positions. On the most widely held item on that ballot — APPROVAL, ON AN ADVISORY BASIS, OF THE EXECUTIVE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE… — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CORBUS PHARMACEUTICALS HOLDINGS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 19, 2025.

CORBUS PHARMACEUTICALS HOLDINGS INC. proxy season coverage: 2024-2025 (this page).

Download data (CSV): ballot items · votes by manager · column guide.